SEC Form 4 · accession 0001178913-26-003472
COMPUGEN LTD · CGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zurit Levine
Officer — SVP, Business Development
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001119774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 9, 2026 | M | 1,875 | $0.8292 | A | 31,250 | D | |
| Ordinary Shares | Jul 9, 2026 | S | 1,875 | $2.50 | D | 29,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F2 | $0.8292 | Jul 9, 2026 | M | 1,875 | D | — | Nov 9, 2032 | Ordinary Shares | 1,875 | 3,750 | D |
Explanation of responses
- F1This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.
- F2This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.